Adiposity in Chinese people with type 1 diabetes

World J Diabetes. 2024 Jul 15;15(7):1404-1408. doi: 10.4239/wjd.v15.i7.1404.

Abstract

Adiposity, synonymous with obesity, is prevalent among both children and adults with type 1 diabetes in China. Recent literature underscored the patho-physiological and socioeconomic factors associated with adiposity, and consistently highlighted its impact on cardiovascular, kidney, and metabolic diseases among Chinese individuals with type 1 diabetes. Addressing and managing adiposity in individuals with type 1 diabetes are complicated and entail comprehensive approaches including lifestyle modifications, cognitive-behavioral therapy, insulin dose titration, and other diabetes treatment medications. The condition calls for coordination among policymakers, researchers, clinicians, and patients.

Keywords: Anti-obesity medications; China; Metabolic syndrome; Obesity; Type 1 diabetes.

Publication types

  • Editorial